Latest Breaking News On - He rptx us7602731025 - Page 1 : comparemela.com

Repare Therapeutics Inc., , a leading clinical-stage precision oncology company, today announced that, in connection with the appointment of Daniel Belanger as the Company’s EVP, Human. | May 22, 2023

Daniel belangerRepare therapeutics incHuman resourcesCompensation committeeIncentive planNasdaq listing ruleRepare therapeuticsRepare therapeutics inc stock exchangePress releaseHe rptx us7602731025